Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: A case series and meta-analysis

Journal of Children's Orthopaedics

Volumn 6, Issue 4, 2012, Pages 297-306

  Dohin, Bruno ^a   Kohler, Remi ^b  

^a UNIVERSITÉ JEAN MONNET   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Bone morphogenetic proteins; Child; Congenital pseudarthrosis; Induce membrane; Neurofibromatosis

Indexed keywords

EID: 84865564914     PISSN: 18632521     EISSN: 18632548     Source Type: Journal    
DOI: 10.1007/s11832-012-0421-3     Document Type: Article

References (56)

1. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1(Pt 2): S151-S158.
2. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R et al (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A(12): 2123-2134.
3. Urist MR (1965) Bone: formation by autoinduction. Science 150(3698): 893-899.
4. Urist MR, Strates BS (1971) Bone morphogenetic protein. J Dent Res 50(6): 1392-1406.
5. Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL et al (2003) BMP signaling components are expressed in human fracture callus. Bone 33(3): 362-371.
6. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22(4): 233-241.
7. Salkeld SL, Patron LP, Barrack RL, Cook SD (2001) The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 83-A(6): 803-816.
8. Ripamonti U, van Den Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH (1996) Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13(3-4): 273-289 (color plates III-VIII, pre. bk).
9. Obert L, Deschaseaux F, Garbuio P (2005) Critical analysis and efficacy of BMPs in long bones non-union. Injury 36(Suppl 3): S38-S42.
10. Steib JP, Bouchaïb J, Walter A, Schuller S, Charles YP (2010) Could an osteoinductor result in degeneration of a neurofibroma in NF1? Eur Spine J 19(Suppl 2): S220-S225.
11. McCarthy RE (1982) Amputation for congenital pseudarthrosis of the tibia. Indications and techniques. Clin Orthop Relat Res 166: 58-61.
12. Fabeck L, Ghafil D, Gerroudj M, Baillon R, Delincé P (2006) Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Br 88(1): 116-118.
13. Anticevic D, Jelic M, Vukicevic S (2006) Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report. J Pediatr Orthop B 15(3): 220-221.
14. Lee FY, Sinicropi SM, Lee FS, Vitale MG, Roye DP Jr, Choi IH (2006) Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases. J Bone Joint Surg Am 88(3): 627-633.
15. Kujala S, Vähäsarja V, Serlo W, Jalovaara P (2008) Treatment of congenital pseudarthrosis of the tibia with native bovine BMP: a case report. Acta Orthop Belg 74(1): 132-136.
16. Dohin B, Dahan-Oliel N, Fassier F, Hamdy R (2009) Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience. Clin Orthop Relat Res 467(12): 3230-3238.
17. Richards BS, Oetgen ME, Johnston CE (2010) The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series. J Bone Joint Surg Am 92(1): 177-185.
18. Spiro AS, Babin K, Lipovac S, Stenger P, Mladenov K, Rupprecht M et al (2011) Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series. J Bone Joint Surg Br 93(5): 695-699.
19. Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E et al (2000) Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9(1): 11-15.
20. Charnley J (1956) Congenital pseudarthrosis of the tibia treated by intramedullary nail. J Bone Joint Surg Am 38-A(2): 283-290.
21. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL (2004) Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg Am 86-A(6): 1186-1197.
22. Grill F, Bollini G, Dungl P, Fixsen J, Hefti F, Ippolito E et al (2000) Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9(2): 75-89.
23. Ilizarov GA, Gracheva VI (1971) Bloodless treatment of congenital pseudarthrosis of the crus with simultaneous elimination of shortening using dosed distraction. Ortop Travmatol Protez 32(2): 42-46.
24. Keret D, Bollini G, Dungl P, Fixsen J, Grill F, Hefti F et al (2000) The fibula in congenital pseudoarthrosis of the tibia: the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9(2): 69-74.
25. Ohnishi I, Sato W, Matsuyama J, Yajima H, Haga N, Kamegaya M et al (2005) Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan. J Pediatr Orthop 25(2): 219-224.
26. Romanus B, Bollini G, Dungl P, Fixsen J, Grill F, Hefti F et al (2000) Free vascular fibular transfer in congenital pseudoarthrosis of the tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9(2): 90-93.
27. Thabet AM, Paley D, Kocaoglu M, Eralp L, Herzenberg JE, Ergin ON (2008) Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report. Clin Orthop Relat Res 466(12): 2981-2994.
28. Toh S, Harata S, Tsubo K, Inoue S, Narita S (2001) Combining free vascularized fibula graft and the Ilizarov external fixator: recent approaches to congenital pseudarthrosis of the tibia. J Reconstr Microsurg 17(7): 497-508; discussion 509.
29. Weiland AJ, Daniel RK (1980) Congenital pseudarthrosis of the tibia: treatment with vascularized autogenous fibular grafts. A preliminary report. Johns Hopkins Med J 147(3): 89-95.
30. Cho TJ, Seo JB, Lee HR, Yoo WJ, Chung CY, Choi IH (2008) Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. J Bone Joint Surg Am 90(12): 2735-2744.
31. Schindeler A, Little DG (2008) Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone 42(4): 616-622.
32. Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P (2000) Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9(1): 3-10.
33. Masquelet AC, Fitoussi F, Begue T, Muller GP (2000) Reconstruction of the long bones by the induced membrane and spongy autograft. Ann Chir Plast Esthet 45(3): 346-353.
34. Masquelet AC, Begue T (2010) The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am 41(1): 27-37; table of contents.
35. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL (2005) Use of an intramedullary rod for the treatment of congenital pseudarthrosis of the tibia. Surgical technique. J Bone Joint Surg Am 87 Suppl 1(Pt 1): 33-40.
36. Dormans JP, Krajbich JI, Zuker R, Demuynk M (1990) Congenital pseudarthrosis of the tibia: treatment with free vascularized fibular grafts. J Pediatr Orthop 10(5): 623-628.
37. El-Gammal TA, El-Sayed A, Kotb MM (2004) Telescoping vascularized fibular graft: a new method for treatment of congenital tibial pseudarthrosis with severe shortening. J Pediatr Orthop B 13(1): 48-56.
38. Gilbert A, Brockman R (1995) Congenital pseudarthrosis of the tibia. Long-term followup of 29 cases treated by microvascular bone transfer. Clin Orthop Relat Res 314: 37-44.
39. Kanaya F, Tsai TM, Harkess J (1996) Vascularized bone grafts for congenital pseudarthrosis of the tibia. Microsurgery 17(8): 459-469; discussion 470-1.
40. Kim HW, Weinstein SL (2002) Intramedullary fixation and bone grafting for congenital pseudarthrosis of the tibia. Clin Orthop Relat Res 405: 250-257.
41. Paley D, Catagni M, Argnani F, Prevot J, Bell D, Armstrong P (1992) Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop Relat Res 280: 81-93.
42. Weiland AJ, Weiss AP, Moore JR, Tolo VT (1990) Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Am 72(5): 654-662.
43. Paterson DC, Simonis RB (1985) Electrical stimulation in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Br 67(3): 454-462.
44. Schindeler A, Ramachandran M, Godfrey C, Morse A, McDonald M, Mikulec K et al (2008) Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice. J Orthop Res 26(1): 65-74.
45. Burkhart KJ, Rommens PM (2008) Intramedullary application of bone morphogenetic protein in the management of a major bone defect after an Ilizarov procedure. J Bone Joint Surg Br 90(6): 806-809.
46. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ (2005) Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87(6): 1367-1378.
47. Vaibhav B, Nilesh P, Vikram S, Anshul C (2007) Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 38(11): 1227-1235.
48. Geesink RG, Hoefnagels NH, Bulstra SK (1999) Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81(4): 710-718.
49. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM (2007) Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16(8): 1257-1265.
50. Wong DA, Watters WC 3rd (2007) To err is human: quality and safety issues in spine care. Spine 32(11 Suppl): S2-S8.
51. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG (2006) Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31(24): 2813-2819.
52. Axelrad TW, Steen B, Lowenberg DW, Creevy WR, Einhorn TA (2008) Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br 90(12): 1617-1622.
53. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J et al (2006) Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31(5): 542-547.
54. Wysocki RW, Cohen MS (2007) Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report. J Hand Surg Am 32(5): 647-650.
55. Kohler R, Solla F, Pinson S, Romana C, Chau E, Dohin B (2005) Congenital pseudarthrosis of the forearm in a neurofibromatosis patient: case report and review of the literature. Rev Chir Orthop Reparatrice Appar Mot 91(8): 773-781.
56. Pelissier P, Masquelet AC, Bareille R, Pelissier SM, Amedee J (2004) Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 22(1): 73-79.